ArticleACS medicinal chemistry letters2024

Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer.

Christos Liolios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.